AbbVie, Inc. (ABBV)
220.38
-0.37
(-0.17%)
USD |
NYSE |
Jan 14, 13:52
AbbVie Free Cash Flow: 19.68B for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Amgen, Inc. | 11.54B |
| Gilead Sciences, Inc. | 9.162B |
| Johnson & Johnson | 20.46B |
| Eli Lilly & Co. | 6.436B |
| Merck & Co., Inc. | 13.05B |